Article Text

Download PDFPDF
Patients want to be involved in end-of-life care research
  1. Amara Callistus Nwosu1,
  2. Catriona R Mayland1,
  3. Stephen Mason1,
  4. Andrea Varro2 and
  5. John E Ellershaw1
  1. 1Marie Curie Palliative Care Institute Liverpool (MCPCIL), University of Liverpool, Liverpool, UK
  2. 2Institute of Translational Medicine, University of Liverpool, Liverpool, UK
  1. Correspondence to Dr Amara Callistus Nwosu, Marie Curie Palliative Care Institute Liverpool (MCPCIL), Department of Molecular & Clinical Cancer Medicine, Cancer Research Centre, University of Liverpool, 200 London Rd, Liverpool L3 9TA, UK;

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Advances in multimodal cancer-directed treatment have improved survival for metastatic cancer patients. In the Western world the combination of various demographic, health-related and sociological factors will contribute to increased comorbidities and mortality over the next decade. A careful, evidence-based approach is necessary to address the inevitable challenges, which will be posed by an increasingly aged population that will require supportive care towards the end of their lives.1 Further investment in palliative care research is required to generate the evidence which will improve the care delivered to patients approaching death.2 Currently, funding for end-of-life and palliative care research is inadequate. Data on UK research funding by National Cancer Research Institute partners in …

View Full Text


  • Contributors All authors of this letter have directly participated in its drafting. All authors of this letter have read and approved the final version submitted.

  • Funding The ‘Friends of the University of Liverpool’ has provided funding, to the sum of £10,000, to cover equipment costs and running costs attributable to the study.

  • Competing interests None.

  • Ethics approval This study received a favorable ethical opinion from the North Wales Research Ethics Committee—West in 2012.

  • Provenance and peer review Not commissioned; internally peer reviewed.